Neuromuscular disease and the pulmonologist

Area of Science:

• Neurology
• Genetics
• Internal Medicine

Background:

• Neuromuscular disorders (NMDs) are a diverse group of conditions affecting nerve and muscle function.
• Their heterogeneity presents ongoing challenges in diagnosis, classification, and treatment.
• Recent years have seen incremental progress in understanding and managing these complex diseases.

Purpose of the Study:

• To review recent updates in the general management and treatment of NMDs.
• To highlight key advancements in specific NMDs including muscular dystrophy, myotonic dystrophy, mitochondrial myopathy, spinal muscular atrophy, and hereditary neuropathies.

Main Methods:

• Literature review focusing on recent publications and clinical advancements in NMDs.
• Synthesis of information regarding diagnostic criteria, classification systems, and therapeutic strategies.
• Emphasis on multidisciplinary care and risk management.

Main Results:

• Improvements in morbidity and mortality for various NMDs are potentially achievable.
• Key factors include enhanced identification and classification, careful management of anesthetic/surgical risks, and aggressive pulmonary care.
• A proactive, multidisciplinary, standard-of-care approach is crucial.
• While innovative therapies are under investigation, no new interventions have yet been approved.

Conclusions:

• Significant progress has been made in the field of neuromuscular diseases.
• The heterogeneous and rare nature of NMDs makes diagnosis and treatment a persistent clinical and research challenge.
• Clinician and researcher awareness is vital for effective identification and management of NMDs.